Literature DB >> 31857439

Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure.

Amanda J Stephens1, Jessica A Kennard1, Christine K Fitzsimmons1, Madhavi Manyam1, James E Kendrick1, Charanjeet Singh2, Nathalie D McKenzie1, Sarfraz Ahmad3, Robert W Holloway1.   

Abstract

PURPOSE: To establish the bilateral pelvic concordance rate of the sentinel lymph node (SLN) and determine the likelihood of lymph node metastasis in cases of mapping failure.
METHODS: A database analysis was performed on 414 patients with clinical stage I endometrial cancer who underwent SLN mapping followed by robotic hysterectomy and completion pelvic (n=414, 100%) and aortic (n=186, 44.9%) lymphadenectomy from March 2011 to August 2016. Stage, histology, SLN sites, and surgico-pathologic findings were analyzed. The bilateral concordance rate of SLN location, successful unilateral and bilateral mapping rates, false negative rate, and non-SLN metastasis associated with mapping failure were calculated.
RESULTS: Histologies included 354 (85.5%) endometrioid, 39 (9.4%) serous, 16 (3.9%) carcinosarcoma, 4 (1.0%) clear cell, and 1 (0.2%) undifferentiated. Final stages included 262 (63.3%) IA, 36 (8.7%) IB, 15 (3.6%) II, 6 (1.4%) IIIA, 68 (16.4%) IIIC1, and 27 (6.5%) IIIC2. Bilateral SLN mapping was successful in 355 (85.7%) patients, and 266 (74.9%) demonstrated mapping to the symmetrical lymphatic group contralaterally. The mapping failure rate was 13.5% (56/414) unilaterally and 0.7% (3/414) bilaterally. SLN locations were external iliac (69.1%), obturator (25.1%), internal iliac (2.2%), common iliac (1.9%), pre-sacral (0.9%), aortic (0.4%), parametrial (0.3%), and para-rectal (0.1%). Lymph node metastases were identified in 95 (22.9%) pelvic and 27 (6.5%) aortic nodes. 10 (16.9%) cases with mapping failure had lymph node metastasis on completion lymphadenectomy, similar to the proportion of SLNs with metastases (p=0.35). However, macro-metastases were more common in mapping failure completion lymphadenectomies than in the positive SLNs (80% vs 22.3%, p<0.001).
CONCLUSION: The contralateral SLN location concordance rate was 75%. Most SLNs were along the medial external iliac or obturator locations. The rate of positive lymph nodes associated with SLN mapping failure was 16.9%, similar to the overall node-positive rate. The detection of pelvic node metastasis with SLN mapping failure was largely populated with macro-metastases and confirms the necessity of completion lymphadenectomy with mapping failure. © IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  SLN and lympadenectomy; lymph nodes; sentinel lymph node; surgical procedures, operative; uterine cancer

Mesh:

Year:  2019        PMID: 31857439     DOI: 10.1136/ijgc-2019-000915

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Sentinel Node Biopsy for Endometrial Cancer by Retroperitoneal Transvaginal Natural Orifice Transluminal Endoscopic Surgery: A Preliminary Study.

Authors:  Daniela Huber; Yannick Hurni
Journal:  Front Surg       Date:  2022-05-09

2.  Sentinel lymph node detection in endometrial cancer with indocyanine green: laparoscopic versus robotic approach.

Authors:  N Bizzarri; S Restaino; S Gueli Alletti; G Monterossi; A Gioè; E La Fera; V Gallotta; A Fagotti; G Scambia; F Fanfani
Journal:  Facts Views Vis Obgyn       Date:  2021-03-31

3.  A Model to Identify Candidates for Lymph Node Dissection Among Patients With High-Risk Endometrial Endometrioid Carcinoma According to Mayo Criteria.

Authors:  Wen Lu; Xiaoyue Chen; Jingyi Ni; Zhen Li; Tao Su; Shuangdi Li; Xiaoping Wan
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

4.  The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis.

Authors:  Lara C Burg; Shenna Verheijen; Ruud L M Bekkers; Joanna IntHout; Robert W Holloway; Salih Taskin; Sarah E Ferguson; Yu Xue; Antonino Ditto; Glauco Baiocchi; Andrea Papadia; Giorgio Bogani; Alessandro Buda; Roy F P M Kruitwagen; Petra L M Zusterzeel
Journal:  J Gynecol Oncol       Date:  2022-06-28       Impact factor: 4.756

5.  Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.

Authors:  Hans Nagar; Nina Wietek; Richard J Goodall; Will Hughes; Mia Schmidt-Hansen; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.